Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research

BACKGROUND: Renin‐angiotensin aldosterone system (RAAS) inhibitor—COVID‐19 studies, observational in design, appear to use biased methods that can distort the interaction between RAAS inhibitor use and COVID‐19 risk. This study assessed the extent of bias in that research and reevaluated RAAS inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Loader, Jordan, Taylor, Frances C., Lampa, Erik, Sundström, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Systematic Review and Meta‐analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238740/
https://www.ncbi.nlm.nih.gov/pubmed/35624081
http://dx.doi.org/10.1161/JAHA.122.025289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238740/
https://www.ncbi.nlm.nih.gov/pubmed/35624081
http://dx.doi.org/10.1161/JAHA.122.025289

Ejemplares similares